Literature DB >> 24402214

Amitriptyline, clomipramine, and maprotiline attenuate the inflammatory response by inhibiting neutrophil migration and mast cell degranulation.

José Alves Gurgel1, Roberto César Pereira Lima-Júnior1, Cristiano Oliveira Rabelo1, Breno Bezerra Gomes Pinho Pessoa1, Gerly Anne Castro Brito2, Ronaldo Albuquerque Ribeiro1.   

Abstract

OBJECTIVE: Despite the recognized anti-inflammatory potential of heterocyclic antidepressants, the mechanisms concerning their modulating effects are not completely known. Thus, we evaluated the anti-inflammatory effect of amitriptyline, clomipramine, and maprotiline and the possible modulating properties of these drugs on neutrophil migration and mast cell degranulation.
METHODS: The hind paw edema and air-pouch models of inflammation were used. Male Wistar rats were treated with saline, amitriptyline, clomipramine or maprotiline (10, 30, or 90 mg/kg, per os [p.o.]) 1 h before the injection of carrageenan (300 μg/0.1 mL/paw) or dextran (500 μg/0.1 mL/paw). Then, edema formation was measured hourly. Neutrophil migration to carrageenan (500 μg/pouch) and N-formyl-methionyl-leucyl-phenylalanine (fMLP) (10-6 M/mL/pouch) was also investigated in 6-day-old air-pouch cavities. Compound 48/80-induced mast cell degranulation was assessed in the mesenteric tissues of antidepressant-treated rats.
RESULTS: All tested antidepressants prevented both carrageenan- and dextran-induced edema. The anti-inflammatory effect of these drugs partially depends on the modulation of neutrophil migration, since they significantly counteracted the chemotactic response of both carrageenan and fMLP (p < 0.01). Furthermore, amitriptyline, clomipramine and maprotiline inhibited compound 48/80-induced mast cell degranulation (p < 0.001).
CONCLUSIONS: These results suggest an important anti-inflammatory role of heterocyclic antidepressants, which is dependent on the modulation of neutrophil migration and mast cell stabilization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24402214     DOI: 10.1590/1516-4446-2012-0977

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  8 in total

1.  Models of inflammation: carrageenan air pouch.

Authors:  Djane B Duarte; Michael R Vasko; Jill C Fehrenbacher
Journal:  Curr Protoc Pharmacol       Date:  2012-03

2.  Amitriptyline Downregulates Chronic Inflammatory Response to Biomaterial in Mice.

Authors:  Karina Scheuermann; Laura Alejandra Ariza Orellano; Celso Tarso Rodrigues Viana; Clara Tolentino Machado; Marcela Guimarães Takahashi Lazari; Luciano Santos Aggum Capettini; Silvia Passos Andrade; Paula Peixoto Campos
Journal:  Inflammation       Date:  2020-10-09       Impact factor: 4.092

3.  Venlafaxine HCl Encapsulated in Niosome: Green and Eco-friendly Formulation for the Management of Pain.

Authors:  Seyyed Mohammad Hassan Hashemi; Reza Enayatifard; Jafar Akbari; Majid Saeedi; Mohammad Seyedabadi; Katayoun Morteza-Semnani; Amirhossein Babaei; Kofi Asare-Addo; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2022-05-20       Impact factor: 3.246

4.  The anti-inflammatory effects of venlafaxine in the rat model of carrageenan-induced paw edema.

Authors:  Valiollah Hajhashemi; Mohsen Minaiyan; Hamid Reza Banafshe; Azam Mesdaghinia; Alireza Abed
Journal:  Iran J Basic Med Sci       Date:  2015-07       Impact factor: 2.699

5.  Maprotiline inhibits LPS-induced expression of adhesion molecules (ICAM-1 and VCAM-1) in human endothelial cells.

Authors:  Laleh Rafiee; Valiollah Hajhashemi; Shaghayegh Haghjooy Javanmard
Journal:  Res Pharm Sci       Date:  2016 Mar-Apr

Review 6.  Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects.

Authors:  Brigitte A Brouwer; Bianca T A de Greef; Janneke G J Hoeijmakers; Margot Geerts; Maarten van Kleef; Ingemar S J Merkies; Catharina G Faber
Journal:  Drugs Aging       Date:  2015-08       Impact factor: 3.923

7.  Amitriptyline protects against TNF-α-induced atrophy and reduction in synaptic markers via a Trk-dependent mechanism.

Authors:  Eimear O'Neill; Billy Kwok; Jennifer S Day; Thomas J Connor; Andrew Harkin
Journal:  Pharmacol Res Perspect       Date:  2016-03-08

Review 8.  Pharmacological treatment options for mast cell activation disease.

Authors:  Gerhard J Molderings; Britta Haenisch; Stefan Brettner; Jürgen Homann; Markus Menzen; Franz Ludwig Dumoulin; Jens Panse; Joseph Butterfield; Lawrence B Afrin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-30       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.